- November 3, 2022
- Newsletter
- 617-430-5616
Menu
Menu
Menu
Menu
Menu
» Home » Drug Database » rosmarinic acid
ADVERTISEMENT
ADVERTISEMENT
» Home » Drug Database » rosmarinic acid
Brand Name :
Synonyms :
Class :
No drug interaction found for rosmarinic acid and .
choline magnesium trisalicylate
Nonsteroidal Anti-Inflammatory Agents: they may increase the toxic effect of salicylates
may have an increased anticoagulant effect when combined with vitamin k antagonists
may have an increased anticoagulant effect when combined with vitamin k antagonists
may have an increased anticoagulant effect when combined with vitamin k antagonists
may have an increased anticoagulant effect when combined with vitamin k antagonists
may have an increased anticoagulant effect when combined with vitamin k antagonists
may increase the toxic effect
may Increase the adverse effect of NSAIDs
may Increase the adverse effect of NSAIDs
may increase the adverse effect of nonsteroidal anti-inflammatory agents
may increase the nephrotoxic effect of nonsteroidal anti-inflammatory agents
may increase the adverse effect of nonsteroidal anti-inflammatory agents
may increase the anticoagulant effect of nonsteroidal anti-inflammatory agent
may decrease the antihypertensive effect of nonsteroidal anti-inflammatory agents
may diminish the effectiveness of reducing proteinuria when combined with sparsentan
may increase the toxic effect of salicylates
may increase the toxic effect of nonsteroidal anti-inflammatory agents
may have an increasingly adverse effect when combined with dabigatran etexilate
may have an increased anticoagulant effect when combined with heparin
may enhance the serum concentration when combined with lithium
may enhance the serum concentration when combined with methotrexate
may enhance the serum concentration when combined with pralatrexate
may have an increasingly adverse effect when combined with rivaroxaban
choline magnesium trisalicylate
may have an increasingly adverse effect when combined with salicylates
may have an increased antiplatelet effect when combined with NSAIDs
may have an increased antiplatelet effect when combined with NSAIDs
may have an increased antiplatelet effect when combined with NSAIDs
may have an increased antiplatelet effect when combined with NSAIDs
may have an increased antiplatelet effect when combined with NSAIDs
may have an increased nephrotoxic effect when combined with tenofovir products
aspirin: they may increase the toxic effect of nonsteroidal anti-inflammatory agents
may enhance the concentration of serum when combined with lithium
may diminish the excretion when combined with aminoglycosides
neomycin/polymyxin B/bacitracin topical
may diminish the excretion when combined with aminoglycosides
the antiplatelet effect of NSAIDs can be increased with combined SSRIs
the antiplatelet effect of NSAIDs can be increased with combined SSRIs
tenofovir disoproxil fumarate or tenofovir DF
nephrotoxicity associated with tenofovir products may increase with NSAIDs when combined
NSAIDs may enhance the risk of adverse/toxic effect of other NSAIDs
NSAIDs may enhance the risk of adverse/toxic effect of other NSAIDs
NSAIDs may enhance the risk of adverse/toxic effect of other NSAIDs
NSAIDs may enhance the risk of adverse/toxic effect of other NSAIDs
NSAIDs may enhance the risk of adverse/toxic effect of other NSAIDs
SSRIs increase the antiplatelet effect of NSAIDs
SSRIs increase the antiplatelet effect of NSAIDs
SSRIs increase the antiplatelet effect of NSAIDs
SSRIs increase the antiplatelet effect of NSAIDs
SSRIs increase the antiplatelet effect of NSAIDs
drugs that are eliminated by active tubular secretion should be avoided due to nephrotoxicity when taken along with nRTI, where these decrease renal function and increase tenofovir-related adverse effects by increasing its level in the body, which needs to be avoided
drugs that are eliminated by active tubular secretion should be avoided due to nephrotoxicity when taken along with nRTI, where these decrease renal function and increase tenofovir-related adverse effects by increasing its level in the body, which needs to be avoided
drugs that are eliminated by active tubular secretion should be avoided due to nephrotoxicity when taken along with nRTI, where these decrease renal function and increase tenofovir-related adverse effects by increasing its level in the body, which needs to be avoided
it increases the toxicity of NSAIDs
NSAIDs may enhance the risk of adverse/toxic effect of other NSAIDs
NSAIDs may enhance the risk of adverse/toxic effect of other NSAIDs
NSAIDs may enhance the risk of adverse/toxic effect of other NSAIDs
NSAIDs may enhance the risk of adverse/toxic effect of other NSAIDs
NSAIDs may enhance the risk of adverse/toxic effect of other NSAIDs
may increase the toxic effect of non-steroidal anti-inflammatory drugs
may increase the antiplatelet effect of nonsteroidal anti-inflammatory agents
may increase the adverse effect of nonsteroidal anti-inflammatory agents
may decrease the therapeutic effect of prostaglandins
may have an increasingly adverse effect when combined with NSAIDs
may have an increasingly adverse effect when combined with NSAIDs
it increases the toxicity of NSAIDs
angiotensin II receptor blockers increase the toxicity of NSAIDs
angiotensin II receptor blockers increase the toxicity of NSAIDs
angiotensin II receptor blockers increase the toxicity of NSAIDs
angiotensin II receptor blockers increase the toxicity of NSAIDs
angiotensin II receptor blockers increase the toxicity of NSAIDs
NSAIDs increase the toxicity of bisphosphonate derivatives
NSAIDs increase the toxicity of bisphosphonate derivatives
NSAIDs increase the toxicity of bisphosphonate derivatives
NSAIDs increase the toxicity of bisphosphonate derivatives
may decrease the excretion of aminoglycosides
may decrease the excretion of aminoglycosides
may decrease the excretion of aminoglycosides
may decrease the excretion of aminoglycosides
may decrease the excretion of aminoglycosides
may enhance the adverse/toxic effect of bisphosphonate derivatives
may enhance the adverse/toxic effect of bisphosphonate derivatives
may enhance the adverse/toxic effect of bisphosphonate derivatives
may enhance the adverse/toxic effect of bisphosphonate derivatives
may reduce the therapeutic effect of prostaglandins
may reduce the therapeutic effect of prostaglandins
NSAIDs may diminish the effect of beta-blockers
NSAIDs may diminish the effect of beta-blockers
NSAIDs may diminish the effect of beta-blockers
NSAIDs may diminish the effect of beta-blockers
NSAIDs may diminish the effect of beta-blockers
may enhance the nephrotoxic effect of 5-Aminosalicylic Acid Derivatives
may enhance the nephrotoxic effect of 5-Aminosalicylic Acid Derivatives
may enhance the adverse/toxic effect of corticosteroids
may enhance the adverse/toxic effect of corticosteroids
may enhance the adverse/toxic effect of corticosteroids
may enhance the adverse/toxic effect of corticosteroids
may enhance the adverse/toxic effect of corticosteroids
may reduce the effect of loop diuretics
may reduce the effect of loop diuretics
may reduce the effect of loop diuretics
choline magnesium trisalicylate
may enhance the adverse effect of salicylates
may reduce the effect of beta-blockers
may reduce the effect of beta-blockers
may reduce the effect of beta-blockers
may reduce the effect of beta-blockers
may reduce the effect of beta-blockers
may reduce the effect of beta-blockers
may have an increased neuroexcitatory and/or seizure-potentiating effect when combined with quinolones
may have an increased neuroexcitatory and/or seizure-potentiating effect when combined with quinolones
may decrease the antihypertensive effect when combined with beta-blockers
may decrease the antihypertensive effect when combined with beta-blockers
may enhance the effect of anticoagulants
may enhance the effect of anticoagulants
may enhance the effect of anticoagulants
may enhance the effect of anticoagulants
may enhance the effect of anticoagulants
may reduce the antihypertensive effect
may reduce the antihypertensive effect
may increase the risk of adverse effects
may reduce the rate of excretion of aminoglycosides
neomycin/polymyxin B/bacitracin topical
may reduce the rate of excretion of aminoglycosides
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
It may increase the adverse effects when combined with Corticosteroids (Ophthalmic)
It may increase the adverse effects when combined with Corticosteroids (Ophthalmic)
It may increase the adverse effects when combined with Corticosteroids (Ophthalmic)
It may increase the adverse effects when combined with Corticosteroids (Ophthalmic)
It may increase the adverse effects when combined with Corticosteroids (Ophthalmic)
It may increase the adverse effects when combined with Corticosteroids (Ophthalmic)
It may increase the adverse effects when combined with Corticosteroids (Ophthalmic)
It may increase the adverse effects when combined with Corticosteroids (Ophthalmic)
It may increase the adverse effects when combined with Corticosteroids (Ophthalmic)
may increase the effect of anticoagulant activity
may increase the effect of anticoagulant activity
may increase the effect of anticoagulant activity
may increase the effect of anticoagulant activity
may increase the effect of anticoagulant activity
may decrease the antihypertensive effect when combined with beta-blockers
may decrease the antihypertensive effect when combined with beta-blockers
may decrease the antihypertensive effect when combined with beta-blockers
nonsteroidal anti-inflammatory agents: they may decrease the therapeutic effect when combined with thiazides
nonsteroidal anti-inflammatory agents: they may decrease the therapeutic effect when combined with thiazides
nonsteroidal anti-inflammatory agents: they may decrease the therapeutic effect when combined with thiazides
nonsteroidal anti-inflammatory agents: they may decrease the therapeutic effect when combined with thiazides
may diminish the effect of antihypertensive activity
may diminish the effect of antihypertensive activity
may diminish the effect of antihypertensive activity
may diminish the effect of antihypertensive activity
may diminish the effect of antihypertensive activity
Nonsteroidal Anti-Inflammatory Agents: they may increase the toxic effect of corticosteroids
Nonsteroidal Anti-Inflammatory Agents: they may decrease the therapeutic effect of Angiotensin II Receptor antagonist
Nonsteroidal Anti-Inflammatory Agents: they may decrease the therapeutic effect of Angiotensin II Receptor antagonist
Nonsteroidal Anti-Inflammatory Agents: they may decrease the therapeutic effect of Angiotensin II Receptor antagonist
Nonsteroidal Anti-Inflammatory Agents: they may decrease the therapeutic effect of Angiotensin II Receptor antagonist
Nonsteroidal Anti-Inflammatory Agents: they may decrease the therapeutic effect of Angiotensin II Receptor antagonist
Nonsteroidal Anti-Inflammatory Agents: they may decrease the therapeutic effect of Angiotensin-Converting Enzyme Inhibitors
Nonsteroidal Anti-Inflammatory Agents: they may decrease the therapeutic effect of Angiotensin-Converting Enzyme Inhibitors
Nonsteroidal Anti-Inflammatory Agents: they may decrease the therapeutic effect of Angiotensin-Converting Enzyme Inhibitors
Nonsteroidal Anti-Inflammatory Agents: they may decrease the therapeutic effect of Angiotensin-Converting Enzyme Inhibitors
Nonsteroidal Anti-Inflammatory Agents: they may decrease the therapeutic effect of Angiotensin-Converting Enzyme Inhibitors
may decrease the antihypertensive effect when combined with beta-blockers
may decrease the antihypertensive effect when combined with beta-blockers
may decrease the antihypertensive effect when combined with beta-blockers
NSAIDs may increase the nephrotoxic effect of 5-aminosalicylic acid derivatives
NSAIDs may increase the nephrotoxic effect of 5-aminosalicylic acid derivatives
May increase the adverse/toxic effect of NSAIDs
May increase the adverse/toxic effect of NSAIDs
May increase the adverse/toxic effect of NSAIDs
May increase the adverse/toxic effect of NSAIDs
May increase the adverse/toxic effect of NSAIDs
may reduce the antihypertensive effect of beta-blockers
may reduce the antihypertensive effect of beta-blockers
may reduce the antihypertensive effect of beta-blockers
may reduce the antihypertensive effect of beta-blockers
may reduce the antihypertensive effect of beta-blockers
may decrease the absorption of NSAIDs
may enhance the adverse/toxic effect of NSAIDs
may enhance the adverse/toxic effect of NSAIDs
may enhance the adverse/toxic effect of NSAIDs
may enhance the adverse/toxic effect of NSAIDs
may enhance the adverse/toxic effect of NSAIDs
may diminish the diuretic effect of loop diuretics
may diminish the diuretic effect of loop diuretics
may diminish the diuretic effect of loop diuretics
may enhance the antiplatelet effect of NSAIDs
may enhance the antiplatelet effect of NSAIDs
may enhance the antiplatelet effect of NSAIDs
may enhance the antiplatelet effect of NSAIDs
may enhance the antiplatelet effect of NSAIDs
may increase the adverse/toxic effect of NSAIDs
they increase the toxicity of metformin
may decrease the therapeutic effect
may diminish the therapeutic effect
may increase the levels of serum concentration of vancomycin
may enhance the risk of adverse/toxic effect of NSAIDs
may enhance the risk of adverse/toxic effect of NSAIDs
may enhance the risk of adverse/toxic effect of NSAIDs
may enhance the risk of adverse/toxic effect of NSAIDs
may enhance the risk of adverse/toxic effect of NSAIDs
may diminish the diagnostic effect of macimorelin
may increase the anti-coagulant action of anti-coagulants
may enhance the adverse/toxic effect of NSAIDs
may enhance the adverse/toxic effect of NSAIDs
may enhance the adverse/toxic effect of NSAIDs
may enhance the adverse/toxic effect of NSAIDs
may enhance the adverse/toxic effect of NSAIDs
may increase the nephrotoxic effect of nonsteroidal anti-inflammatory agents
may increase the adverse effect of nonsteroidal anti-inflammatory agents
may decrease the therapeutic effect of beta blockers
may increase the toxic effect of angiotensin receptor II blockers
may increase the toxic effect of angiotensin receptor II blockers
lisinopril/hydrochlorothiazide
may increase the hyperkalemic effect of Angiotensin-converting enzyme inhibitors
eprosartan/hydrochlorothiazide
may increase the nephrotoxic effect of thiazide and thiazide like diuretics
may enhance the adverse effect of NSAIDs
may enhance the adverse effect of NSAIDs
may enhance the adverse effect of NSAIDs
may enhance the adverse effect of NSAIDs
may enhance the adverse effect of NSAIDs
may enhance the adverse effect of NSAIDs
may enhance the adverse effect of NSAIDs
may enhance the adverse effect of NSAIDs
may enhance the adverse effect of NSAIDs
may enhance the adverse effect of NSAIDs
may enhance the adverse effect of NSAIDs
may enhance the adverse effect of NSAIDs
may enhance the adverse effect of NSAIDs
may enhance the hypoglycemic effect of beta blockers
may enhance the toxic effect of corticosteroids
may decrease the antihypertensive effect when combined with aliskiren
may diminish the excretion when combined with aminoglycosides
may diminish the excretion when combined with aminoglycosides
may diminish the excretion when combined with aminoglycosides
may diminish the excretion when combined with aminoglycosides
may diminish the excretion when combined with aminoglycosides
may have an increasingly adverse effect when combined with NSAIDs
may have an increasingly adverse effect when combined with bisphosphonate derivatives
may have an increasingly adverse effect when combined with bisphosphonate derivatives
may have an increasingly adverse effect when combined with bisphosphonate derivatives
may have an increasingly adverse effect when combined with bisphosphonate derivatives
may have an increasingly adverse effect when combined with bisphosphonate derivatives
may have an increasingly adverse effect when combined with deferasirox
may have an increased hyponatremic effect when combined with desmopressin
may enhance the serum concentration when combined with digoxin
may decrease the antihypertensive effect when combined with hydralazine
may increase the anti-coagulant effect of Anti-coagulants
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the antiplatelet effect
may increase the antiplatelet effect
may increase the antiplatelet effect
may increase the antiplatelet effect
may increase the antiplatelet effect
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
omacetaxine: they may increase the toxic effect of Nonsteroidal Anti-Inflammatory Agents
sodium acid phosphates: they may increase the nephrotoxic effect of Nonsteroidal Anti-Inflammatory Agents
tacrolimus: they may increase the nephrotoxic effect of Nonsteroidal Anti-Inflammatory drugs
verteporfin: they may increase the serum concentration of Nonsteroidal Anti-Inflammatory Agents
estrogens esterified/methyltestosterone
may increase the thrombogenic effect of estrogen derivatives
drospirenone/ethinyl estradiol/levomefolate
may increase the hyperkalemic effect of Drospirenone-Containing Products
nonsteroidal anti-Inflammatory agents may strengthen the anticoagulant effects of anticoagulants
nonsteroidal anti-Inflammatory agents may strengthen the anticoagulant effects of anticoagulants
nonsteroidal anti-Inflammatory agents may strengthen the anticoagulant effects of anticoagulants
nonsteroidal anti-Inflammatory agents may strengthen the anticoagulant effects of anticoagulants
nonsteroidal anti-Inflammatory agents may strengthen the anticoagulant effects of anticoagulants
The effectiveness of prostaglandins (ophthalmic) may be reduced by the presence of nonsteroidal anti-Inflammatory agents (ophthalmic)
The effectiveness of prostaglandins (ophthalmic) may be reduced by the presence of nonsteroidal anti-Inflammatory agents (ophthalmic)
polyethylene glycol and electrolytes
They may increase the nephrotoxic effect when combined with polyethylene Glycol-electrolyte Solution
may have an increasingly adverse effect when combined with NSAIDs
may have an increasingly adverse effect when combined with NSAIDs
may have an increasingly adverse effect when combined with NSAIDs
framycetin, dexamethasone, and gramicidin
may increase the toxic effect of each other
cyproterone and ethinyl estradiol
may increase the thrombogenic effect when combined
naftazone: they may increase the antiplatelet effect of Nonsteroidal Anti-Inflammatory Agents
tricyclic antidepressants: they may increase the toxic effect of Nonsteroidal Anti-Inflammatory Agents
tricyclic antidepressants: they may increase the toxic effect of Nonsteroidal Anti-Inflammatory Agents
tricyclic antidepressants: they may increase the toxic effect of Nonsteroidal Anti-Inflammatory Agents
tricyclic antidepressants: they may increase the toxic effect of Nonsteroidal Anti-Inflammatory Agents
may increase the nephrotoxic effect of nonsteroidal anti-inflammatory agents
may increase the adverse effect of NSAIDs
when combined, Bisphosphonate Derivative's side effects can be increased with NSAIDs
when combined, Bisphosphonate Derivative's side effects can be increased with NSAIDs
when combined, Bisphosphonate Derivative's side effects can be increased with NSAIDs
when combined, Bisphosphonate Derivative's side effects can be increased with NSAIDs
when combined, Bisphosphonate Derivative's side effects can be increased with NSAIDs
spironolactone and hydrochlorothiazide
antihypertensive actions of potassium-sparing diuretics can be reduced with combined NSAIDs
antihypertensive actions of potassium-sparing diuretics can be reduced with combined NSAIDs
antihypertensive actions of potassium-sparing diuretics can be reduced with combined NSAIDs
antihypertensive actions of potassium-sparing diuretics can be reduced with combined NSAIDs
antihypertensive actions of potassium-sparing diuretics can be reduced with combined NSAIDs
when combined, the antihypertensive effect of Beta-Blockers can be reduced with NSAIDs
may increase the toxic effect of each other when combined
may have an increasingly adverse effect when combined with NSAIDs
ADVERTISEMENT
» Home » Drug Database » rosmarinic acid
Brand Name :
Synonyms :
Class :
